Dementia and Neurocognitive Disorders (대한치매학회지)

Korean Dementia Association (대한치매학회)
권호 표지
DOI QR코드

DOI QR Code

Characteristics of Cerebral Microbleeds

  • Lee, Juyoun (Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine) ;
  • Sohn, Eun Hee (Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine) ;
  • Oh, Eungseok (Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine) ;
  • Lee, Ae Young (Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine)
  • Received : 2018.08.15
  • Accepted : 2018.11.26
  • Published : 2018.09.30
⟨ Previous Next ⟩

Abstract

Cerebral microbleeds (CMBs) are increasingly recognized neuroimaging findings, occurring with cerebrovascular disease, dementia, and aging. CMBs are associated with subsequent hemorrhagic and ischemic stroke, and also with an increased risk of cognitive deterioration and dementia. They occur in the setting of impaired small vessel integrity due to hypertension or cerebral amyloid angiopathy. This review summarizes the concepts, cause or risk factors, histopathological mechanisms, and clinical consequences of CMBs.

Keywords

References

  1. Roob G, Schmidt R, Kapeller P, Lechner A, Hartung HP, Fazekas F. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 1999;52:991-994. https://doi.org/10.1212/WNL.52.5.991
  2. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009;8:165-174. https://doi.org/10.1016/S1474-4422(09)70013-4
  3. Poels MM, Ikram MA, van der Lugt A, Hofman A, Krestin GP, Breteler MM, et al. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke 2011;42:656-661. https://doi.org/10.1161/STROKEAHA.110.607184
  4. Sveinbjornsdottir S, Sigurdsson S, Aspelund T, Kjartansson O, Eiriksdottir G, Valtysdottir B, et al. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry 2008;79:1002-1006. https://doi.org/10.1136/jnnp.2007.121913
  5. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008;70:1208-1214. https://doi.org/10.1212/01.wnl.0000307750.41970.d9
  6. Poels MM, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van der Lugt A, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke 2010;41:S103-S106. https://doi.org/10.1161/STROKEAHA.110.595181
  7. Akoudad S, Wolters FJ, Viswanathan A, de Bruijn RF, van der Lugt A, Hofman A, et al. Association of cerebral microbleeds with cognitive decline and dementia. JAMA Neurol 2016;73:934-943. https://doi.org/10.1001/jamaneurol.2016.1017
  8. Seo SW, Lee BH, Kim EJ, Chin J, Cho YS, Yoon U, et al. Clinical significance of microbleeds in subcortical vascular dementia. Stroke 2007;38:1949-1951. https://doi.org/10.1161/STROKEAHA.106.477315
  9. Cordonnier C, van der Flier WM. Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain 2011;134:335-344. https://doi.org/10.1093/brain/awq321
  10. Koennecke HC. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 2006;66:165-171. https://doi.org/10.1212/01.wnl.0000194266.55694.1e
  11. Lovelock CE, Cordonnier C, Naka H, Al-Shahi Salman R, Sudlow CL, et al.; Edinburgh Stroke Study Group Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke 2010;41:1222-1228. https://doi.org/10.1161/STROKEAHA.109.572594
  12. Wilson D, Charidimou A, Ambler G, Fox ZV, Gregoire S, Rayson P, et al. Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: a meta-analysis. Neurology 2016;87:1501-1510. https://doi.org/10.1212/WNL.0000000000003183
  13. Park MY, Park HJ, Shin DS. Distribution analysis of cerebral microbleeds in Alzheimer's disease and cerebral infarction with susceptibility weighted MR imaging. J Korean Neurol Assoc 2017;35:72-79. https://doi.org/10.17340/jkna.2017.2.2
  14. Akoudad S, Ikram MA, Koudstaal PJ, Hofman A, van der Lugt A, Vernooij MW. Cerebral microbleeds and the risk of mortality in the general population. Eur J Epidemiol 2013;28:815-821. https://doi.org/10.1007/s10654-013-9854-3
  15. Peng Q, Sun W, Liu W, Liu R, Huang Y; CASISP Study Group. Longitudinal relationship between chronic kidney disease and distribution of cerebral microbleeds in patients with ischemic stroke. J Neurol Sci 2016;362:1-6. https://doi.org/10.1016/j.jns.2016.01.015
  16. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822-838. https://doi.org/10.1016/S1474-4422(13)70124-8
  17. Shoamanesh A, Kwok CS, Benavente O. Cerebral microbleeds: histopathological correlation of neuroimaging. Cerebrovasc Dis 2011;32:528-534. https://doi.org/10.1159/000331466
  18. Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA; Angioma Alliance Scientific Advisory Board. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Stroke 2008;39:3222-3230. https://doi.org/10.1161/STROKEAHA.108.515544
  19. Gaviani P, Mullins ME, Braga TA, Hedley-Whyte ET, Halpern EF, Schaefer PS, et al. Improved detection of metastatic melanoma by T2*-weighted imaging. AJNR Am J Neuroradiol 2006;27:605-608.
  20. Nandigam RN, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, et al. MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 2009;30:338-343. https://doi.org/10.3174/ajnr.A1355
  21. Haller S, Vernooij MW, Kuijer JP, Larsson EM, Jager HR, Barkhof F. Cerebral microbleeds: imaging and clinical significance. Radiology 2018;287:11-28. https://doi.org/10.1148/radiol.2018170803
  22. Haacke EM, DelProposto ZS, Chaturvedi S, Sehgal V, Tenzer M, Neelavalli J, et al. Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging. AJNR Am J Neuroradiol 2007;28:316-317.
  23. Cheng AL, Batool S, McCreary CR, Lauzon ML, Frayne R, Goyal M, et al. Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke 2013;44:2782-2786. https://doi.org/10.1161/STROKEAHA.113.002267
  24. Seghier ML, Kolanko MA, Leff AP, Jager HR, Gregoire SM, Werring DJ. Microbleed detection using automated segmentation (MIDAS): a new method applicable to standard clinical MR images. PLoS One 2011;6:e17547. https://doi.org/10.1371/journal.pone.0017547
  25. Kuijf HJ, Brundel M, de Bresser J, van Veluw SJ, Heringa SM, Viergever MA, et al. Semi-automated detection of cerebral microbleeds on 3.0 T MR images. PLoS One 2013;8:e66610. https://doi.org/10.1371/journal.pone.0066610
  26. Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jager HR, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 2009;73:1759-1766. https://doi.org/10.1212/WNL.0b013e3181c34a7d
  27. Cordonnier C, Potter GM, Jackson CA, Doubal F, Keir S, Sudlow CL, et al. improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke 2009;40:94-99. https://doi.org/10.1161/STROKEAHA.108.526996
  28. Qiu C, Ding J, Sigurdsson S, Fisher DE, Zhang Q, Eiriksdottir G, et al. Differential associations between retinal signs and CMBs by location: the AGES-Reykjavik Study. Neurology 2018;90:e142-e148. https://doi.org/10.1212/WNL.0000000000004792
  29. Granger JP. An emerging role for inflammatory cytokines in hypertension. Am J Physiol Heart Circ Physiol 2006;290:H923-H924. https://doi.org/10.1152/ajpheart.01278.2005
  30. Shoamanesh A, Preis SR, Beiser AS, Vasan RS, Benjamin EJ, Kase CS, et al. Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study. Neurology 2015;84:825-832. https://doi.org/10.1212/WNL.0000000000001279
  31. Fisher M. Cerebral microbleeds and thrombolysis: clinical consequences and mechanistic implications. JAMA Neurol 2016;73:632-635. https://doi.org/10.1001/jamaneurol.2016.0576
  32. Jeon SB, Kang DW, Cho AH, Lee EM, Choi CG, Kwon SU, et al. Initial microbleeds at MR imaging can predict recurrent intracerebral hemorrhage. J Neurol 2007;254:508-512. https://doi.org/10.1007/s00415-006-0406-6
  33. Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke 2008;39:497-502. https://doi.org/10.1161/STROKEAHA.107.488791
  34. Hackam DG, Woodward M, Newby LK, Bhatt DL, Shao M, Smith EE, et al. Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation 2011;124:2233-2242. https://doi.org/10.1161/CIRCULATIONAHA.111.055269
  35. Oh MY, Lee H, Kim JS, Ryu WS, Lee SH, Ko SB, et al. Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds. BMC Neurol 2014;14:127. https://doi.org/10.1186/1471-2377-14-127
  36. Yates PA, Villemagne VL, Ellis KA, Desmond PM, Masters CL, Rowe CC. Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Front Neurol 2014;4:205.
  37. Lee SH, Lee ST, Kim BJ, Park HK, Kim CK, Jung KH, et al. Dynamic temporal change of cerebral microbleeds: long-term follow-up MRI study. PLoS One 2011;6:e25930. https://doi.org/10.1371/journal.pone.0025930
  38. McCarron MO, Nicoll JA, Stewart J, Ironside JW, Mann DM, Love S, et al. The apolipoprotein E ${\varepsilon}2$ allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol 1999;58:711-718. https://doi.org/10.1097/00005072-199907000-00005
  39. Greenberg SM, Nandigam RN, Delgado P, Betensky RA, Rosand J, Viswanathan A, et al. Microbleeds versus macrobleeds: evidence for distinct entities. Stroke 2009;40:2382-2386. https://doi.org/10.1161/STROKEAHA.109.548974
  40. Wang Z, Soo YO, Mok VC. Cerebral microbleeds: is antithrombotic therapy safe to administer? Stroke 2014;45:2811-2817. https://doi.org/10.1161/STROKEAHA.114.004286
  41. Pasi M, Charidimou A, Boulouis G, Auriel E, Ayres A, Schwab KM, et al. Mixed-location cerebral hemorrhage/microbleeds: underlying microangiopathy and recurrence risk. Neurology 2018;90:e119-e126. https://doi.org/10.1212/WNL.0000000000004797
  42. Charidimou A, Boulouis G, Pasi M, Auriel E, van Etten ES, Haley K, et al. MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology 2017;88:1157-1164. https://doi.org/10.1212/WNL.0000000000003746
  43. Martinez-Ramirez S, Pontes-Neto OM, Dumas AP, Auriel E, Halpin A, Quimby M, et al. Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology 2013;80:1551-1556. https://doi.org/10.1212/WNL.0b013e31828f1876
  44. Renard D. Cerebral microbleeds: a magnetic resonance imaging review of common and less common causes. Eur J Neurol 2018;25:441-450. https://doi.org/10.1111/ene.13544
  45. Unetani H, Hirai T, Hashimoto M, Ikeda M, Kitajima M, Sakamoto F, et al. Prevalence and topography of small hypointense foci suggesting microbleeds on 3T susceptibility-weighted imaging in various types of dementia. AJNR Am J Neuroradiol 2013;34:984-989. https://doi.org/10.3174/ajnr.A3332
  46. Kato H, Izumiyama M, Izumiyama K, Takahashi A, Itoyama Y. Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 2002;33:1536-1540. https://doi.org/10.1161/01.STR.0000018012.65108.86
  47. Imaizumi T, Horita Y, Hashimoto Y, Niwa J. Dotlike hemosiderin spots on T2*-weighted magnetic resonance imaging as a predictor of stroke recurrence: a prospective study. J Neurosurg 2004;101:915-920. https://doi.org/10.3171/jns.2004.101.6.0915
  48. Bokura H, Saika R, Yamaguchi T, Nagai A, Oguro H, Kobayashi S, et al. Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals. Stroke 2011;42:1867-1871. https://doi.org/10.1161/STROKEAHA.110.601922
  49. van Etten ES, Auriel E, Haley KE, Ayres AM, Vashkevich A, Schwab KM, et al. Incidence of symptomatic hemorrhage in patients with lobar microbleeds. Stroke 2014;45:2280-2285. https://doi.org/10.1161/STROKEAHA.114.005151
  50. Soo YO, Yang SR, Lam WW, Wong A, Fan YH, Leung HH, et al. Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol 2008;255:1679-1686. https://doi.org/10.1007/s00415-008-0967-7
  51. Altmann-Schneider I, Trompet S, de Craen AJ, van Es AC, Jukema JW, Stott DJ, et al. Cerebral microbleeds are predictive of mortality in the elderly. Stroke 2011;42:638-644. https://doi.org/10.1161/STROKEAHA.110.595611
  52. Zhu YC, Chabriat H, Godin O, Dufouil C, Rosand J, Greenberg SM, et al. Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging. J Neurol 2012;259:530-536. https://doi.org/10.1007/s00415-011-6218-3
  53. Liu W, Liu R, Sun W, Peng Q, Zhang W, Xu E, et al. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke 2012;43:2916-2922. https://doi.org/10.1161/STROKEAHA.112.658369
  54. Schuur M, van Swieten JC, Schol-Gelok S, Ikram MA, Vernooij MW, Liu F, et al. Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population. J Neurol Neurosurg Psychiatry 2011;82:41-44. https://doi.org/10.1136/jnnp.2009.176362
  55. Selim M, Diener HC. Atrial fibrillation and microbleeds. Stroke 2017;48:2660-2664. https://doi.org/10.1161/STROKEAHA.117.017085
  56. Greenberg SM, Bacskai BJ, Hyman BT. Alzheimer disease's double-edged vaccine. Nat Med 2003;9:389-390. https://doi.org/10.1038/nm847

Cited by

  1. White matter hyperintensities and the pulsatility index: fellow travelers or partners in crime? vol.77, pp.5, 2018, https://doi.org/10.1590/0004-282x20190061
  2. Strictly Lobar Microbleeds Reflect Amyloid Angiopathy Regardless of Cerebral and Cerebellar Compartments vol.51, pp.12, 2020, https://doi.org/10.1161/strokeaha.119.028487
  3. Cerebral Small Vessel Disease vol.21, pp.24, 2018, https://doi.org/10.3390/ijms21249729
  4. Neurological Critical Care: The Evolution of Cerebrovascular Critical Care vol.49, pp.6, 2018, https://doi.org/10.1097/ccm.0000000000004933
  5. Carotid intima-media thickness and arterial stiffness in relation to cerebral small vessel disease in neurologically asymptomatic individuals with type 1 diabetes vol.58, pp.7, 2021, https://doi.org/10.1007/s00592-021-01678-x
  6. Emerging Applications for Quantitative Susceptibility Mapping in the Detection of Traumatic Brain Injury Pathology vol.467, pp.None, 2018, https://doi.org/10.1016/j.neuroscience.2021.05.030